Moncef Slaoui (Alex Brandon/AP Images)
March 4, 2022 11:03 AM ESTUpdated March 7, 07:40 AM
People
Coronavirus

For­mer Warp Speed chief agrees to pay GSK back $3.9M fol­low­ing sex­u­al ha­rass­ment

Zachary Brennan

Senior Editor

Glax­o­SmithK­line’s long­time R&D chief Mon­cef Slaoui agreed to pay $3.86 mil­lion to his for­mer com­pa­ny as part of claw­back pro­vi­sions the com­pa­ny un­der­took to re­coup …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times